ARTL Q4 2025 Earnings NarrowerThanExpected Loss Despite Zero Revenue Burford Capital Q1 2026 Earnings Massive EPS Miss with 5273 Surprise Drains Investor Confidence NNOX Q4 2025 Earnings Significant EPS Miss as PreRevenue Stage Continues OTF Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status Teledyne Technologies TDY Q1 2026 Earnings EPS Beats Estimates Stock Gains Amid Disciplined Execution